How the Government Can Prevent Individuals from Using Wealth to Cut the Vaccine Line
There are several ways government officials can combat the wealth problem without sacrificing the speed at which vaccines are administered.

Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of December.

Israel’s rich health databases are probably the reason why Pfizer agreed to a deal to expedite deliveries of its vaccine.

The COVID-19 pandemic has posed an impossible set of choices for governments, forcing them to weigh competing interests.

Prior to the recent PREP Act amendment, no federal-level scheme of telehealth oversight existed to date.
